Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The organometallic chemistry of Rhenium spans 11 oxidation states. Since many ligands stabilize several oxidation states, this chemistry is described by ligand type. Re‐Re multiple bonded organometallic complexes, Polynuclear organometallic complexes, and Bioorganometallic Chemistry, uncoverable in this fashion, are treated separately. The CO ligand dominates the chemistry of the lower oxidation states (Re −III to Re II ) most of which is derived from Re 2 (CO) 10 and the consequences of the rupture of its Re‐Re bond. [Re(CO) 5 ] • , [Re(CO) 5 ] − and Re(CO) 5 X are the most important products of Re‐Re homolysis, reduction and oxidation, respectively, and originate a vast chemistry. [ReX x (CO) y L z ] is the largest family of organorhenium complexes. The luminescent fac ‐[ReX(CO) 3 L 2 ] molecules assume high practical relevance in photoresponsive materials and sensors. Polyhydrides [ReH x L y ] lose H 2 upon thermal, photochemical or oxidative activation promoting alkane dehydrogenation. The abundant [Re(CO) x H y ] clusters are important building blocs for catalysts and materials. [ReH(CO) 4 ] n are analogues of cycloalkanes. Mononuclear homoleptic alkyls and aryls of Re in high oxidation states are limited to ReMe 6 and [Re(2‐MeC 6 H 4 ) 4 ]. Instead, carbenes and carbynes, as the remarkable [Re(≡CCMe 3 )(=CHCMe 3 )(CH 2 CMe 3 ) 2 ], are common. Re VII oxo and imido complexes also originate carbene/carbyne complexes active in olefin metathesis catalysis. ReO 3 Me (MTO) is a uniquely versatile catalyst in a wide variety of oxidation and O transfer catalysis. ReO 2 Me derivatives are active catalysts namely in aldehyde olefination. η 2 ‐, η 3 ‐, η 4 ‐ (dienes), η 6 ‐ (arenes) and η 7 ‐ (cycloheptatrienyl) ligands play a limited role in the organorhenium chemistry. Exceptional is, however, the activation of η 2 ‐arenes by Re I complexes. The dearomatized benzene ring in TpRe(CO)(MeIm)(η 2 ‐C 6 H 6 ) reacts as a diene. Unusual alkyne complexes appear in Re III and Re V oxides, e.g. ReR(O)(η 2 ‐RCCR) (R = H, alkyl). [Cp'Re(CO) 2 (η 3 ‐propargyl)] + complexes reveal a fascinating series of structural transformations and rearrangements. The cyclopentadienyl ligand (η 5 ‐C 5 R 5 = Cp’) shapes the large families of complexes of the fragments Cp’ 2 Re (rhenocene) Cp'Re(CO) 2 , [Cp'Re(NO)(PPh 3 )] + and Cp'ReO x X y . Hydrocarbyl transformations at these fragments and the understanding of the stereochemical control in enantioselective transformations of ligands bound to the chiral‐at‐metal fragment [Cp'Re(NO)(PPh 3 )] + are of outstanding relevance. Isoelectronic neutral or negative 6 e donors may enhance these transformations and support new ones. [Cp*Re(CO) 2 ] 2 and [Re(≡CCMe 3 )(OCMe 3 ) 2 ] 2 are rare examples of unsupported dimers of 16e fragments. Re isocyanide and nitrosyl complexes follow most of the structural and chemical patterns found for the carbonyl ligand. However, recent findings revealed that the participation of the O atom of the NO ligand in H bonding may lead to unexpected reactivity. Polynuclear Re complexes span a bewildering variety of synthetic methods and structural motifs. The ultimate rationale for their study is cooperative catalysis, as modelled in alkene hydrogenation with a Re/Pt binuclear complex and applied in petroleum refining with Pt x Re y clusters. Bioorganometallic chemistry is rapidly evolving into practical medical applications in diagnostics and therapy. Stable Re(CO) 3 fragments decorated with biologically active molecules are able to target Re compounds to specific tissues/organs. New synthetic methods have been developed for the synthesis of the required molecules in aqueous solution, avoiding the use of CO gas and classical high pressure synthesis.
The organometallic chemistry of Rhenium spans 11 oxidation states. Since many ligands stabilize several oxidation states, this chemistry is described by ligand type. Re‐Re multiple bonded organometallic complexes, Polynuclear organometallic complexes, and Bioorganometallic Chemistry, uncoverable in this fashion, are treated separately. The CO ligand dominates the chemistry of the lower oxidation states (Re −III to Re II ) most of which is derived from Re 2 (CO) 10 and the consequences of the rupture of its Re‐Re bond. [Re(CO) 5 ] • , [Re(CO) 5 ] − and Re(CO) 5 X are the most important products of Re‐Re homolysis, reduction and oxidation, respectively, and originate a vast chemistry. [ReX x (CO) y L z ] is the largest family of organorhenium complexes. The luminescent fac ‐[ReX(CO) 3 L 2 ] molecules assume high practical relevance in photoresponsive materials and sensors. Polyhydrides [ReH x L y ] lose H 2 upon thermal, photochemical or oxidative activation promoting alkane dehydrogenation. The abundant [Re(CO) x H y ] clusters are important building blocs for catalysts and materials. [ReH(CO) 4 ] n are analogues of cycloalkanes. Mononuclear homoleptic alkyls and aryls of Re in high oxidation states are limited to ReMe 6 and [Re(2‐MeC 6 H 4 ) 4 ]. Instead, carbenes and carbynes, as the remarkable [Re(≡CCMe 3 )(=CHCMe 3 )(CH 2 CMe 3 ) 2 ], are common. Re VII oxo and imido complexes also originate carbene/carbyne complexes active in olefin metathesis catalysis. ReO 3 Me (MTO) is a uniquely versatile catalyst in a wide variety of oxidation and O transfer catalysis. ReO 2 Me derivatives are active catalysts namely in aldehyde olefination. η 2 ‐, η 3 ‐, η 4 ‐ (dienes), η 6 ‐ (arenes) and η 7 ‐ (cycloheptatrienyl) ligands play a limited role in the organorhenium chemistry. Exceptional is, however, the activation of η 2 ‐arenes by Re I complexes. The dearomatized benzene ring in TpRe(CO)(MeIm)(η 2 ‐C 6 H 6 ) reacts as a diene. Unusual alkyne complexes appear in Re III and Re V oxides, e.g. ReR(O)(η 2 ‐RCCR) (R = H, alkyl). [Cp'Re(CO) 2 (η 3 ‐propargyl)] + complexes reveal a fascinating series of structural transformations and rearrangements. The cyclopentadienyl ligand (η 5 ‐C 5 R 5 = Cp’) shapes the large families of complexes of the fragments Cp’ 2 Re (rhenocene) Cp'Re(CO) 2 , [Cp'Re(NO)(PPh 3 )] + and Cp'ReO x X y . Hydrocarbyl transformations at these fragments and the understanding of the stereochemical control in enantioselective transformations of ligands bound to the chiral‐at‐metal fragment [Cp'Re(NO)(PPh 3 )] + are of outstanding relevance. Isoelectronic neutral or negative 6 e donors may enhance these transformations and support new ones. [Cp*Re(CO) 2 ] 2 and [Re(≡CCMe 3 )(OCMe 3 ) 2 ] 2 are rare examples of unsupported dimers of 16e fragments. Re isocyanide and nitrosyl complexes follow most of the structural and chemical patterns found for the carbonyl ligand. However, recent findings revealed that the participation of the O atom of the NO ligand in H bonding may lead to unexpected reactivity. Polynuclear Re complexes span a bewildering variety of synthetic methods and structural motifs. The ultimate rationale for their study is cooperative catalysis, as modelled in alkene hydrogenation with a Re/Pt binuclear complex and applied in petroleum refining with Pt x Re y clusters. Bioorganometallic chemistry is rapidly evolving into practical medical applications in diagnostics and therapy. Stable Re(CO) 3 fragments decorated with biologically active molecules are able to target Re compounds to specific tissues/organs. New synthetic methods have been developed for the synthesis of the required molecules in aqueous solution, avoiding the use of CO gas and classical high pressure synthesis.
The organometallic chemistry of Rhenium spans 11 oxidation states. Since many ligands stabilize several oxidation states, this chemistry is described by ligand type. Re‐Re multiple bonded organometallic complexes, Polynuclear organometallic complexes, and Bioorganometallic Chemistry, uncoverable in this fashion, are treated separately. The CO ligand dominates the chemistry of the lower oxidation states (Re −III to Re II ) most of which is derived from Re 2 (CO) 10 and the consequences of the rupture of its Re‐Re bond. [Re(CO) 5 ] • , [Re(CO) 5 ] − and Re(CO) 5 X are the most important products of Re‐Re homolysis, reduction and oxidation, respectively, and originate a vast chemistry. [ReX x (CO) y L z ] is the largest family of organorhenium complexes. The luminescent fac ‐[ReX(CO) 3 L 2 ] molecules assume high practical relevance in photoresponsive materials and sensors. Polyhydrides [ReH x L y ] lose H 2 upon thermal, photochemical or oxidative activation promoting alkane dehydrogenation. The abundant [Re(CO) x H y ] clusters are important building blocs for catalysts and materials. [ReH(CO) 4 ] n are analogues of cycloalkanes. Mononuclear homoleptic alkyls and aryls of Re in high oxidation states are limited to ReMe 6 and [Re(2‐MeC 6 H 4 ) 4 ]. Instead, carbenes and carbynes, as the remarkable [Re(≡CCMe 3 )(=CHCMe 3 )(CH 2 CMe 3 ) 2 ], are common. Re VII oxo and imido complexes also originate carbene/carbyne complexes active in olefin metathesis catalysis. ReO 3 Me (MTO) is a uniquely versatile catalyst in a wide variety of oxidation and O transfer catalysis. ReO 2 Me derivatives are active catalysts namely in aldehyde olefination. η 2 ‐, η 3 ‐, η 4 ‐ (dienes), η 6 ‐ (arenes) and η 7 ‐ (cycloheptatrienyl) ligands play a limited role in the organorhenium chemistry. Exceptional is, however, the activation of η 2 ‐arenes by Re I complexes. The dearomatized benzene ring in TpRe(CO)(MeIm)(η 2 ‐C 6 H 6 ) reacts as a diene. Unusual alkyne complexes appear in Re III and Re V oxides, e.g. ReR(O)(η 2 ‐RCCR) (R = H, alkyl). [Cp'Re(CO) 2 (η 3 ‐propargyl)] + complexes reveal a fascinating series of structural transformations and rearrangements. The cyclopentadienyl ligand (η 5 ‐C 5 R 5 = Cp’) shapes the large families of complexes of the fragments Cp’ 2 Re (rhenocene) Cp'Re(CO) 2 , [Cp'Re(NO)(PPh 3 )] + and Cp'ReO x X y . Hydrocarbyl transformations at these fragments and the understanding of the stereochemical control in enantioselective transformations of ligands bound to the chiral‐at‐metal fragment [Cp'Re(NO)(PPh 3 )] + are of outstanding relevance. Isoelectronic neutral or negative 6 e donors may enhance these transformations and support new ones. [Cp*Re(CO) 2 ] 2 and [Re(≡CCMe 3 )(OCMe 3 ) 2 ] 2 are rare examples of unsupported dimers of 16e fragments. Re isocyanide and nitrosyl complexes follow most of the structural and chemical patterns found for the carbonyl ligand. However, recent findings revealed that the participation of the O atom of the NO ligand in H bonding may lead to unexpected reactivity. Polynuclear Re complexes span a bewildering variety of synthetic methods and structural motifs. The ultimate rationale for their study is cooperative catalysis, as modelled in alkene hydrogenation with a Re/Pt binuclear complex and applied in petroleum refining with Pt x Re y clusters. Bioorganometallic chemistry is rapidly evolving into practical medical applications in diagnostics and therapy. Stable Re(CO) 3 fragments decorated with biologically active molecules are able to target Re compounds to specific tissues/organs. New synthetic methods have been developed for the synthesis of the required molecules in aqueous solution, avoiding the use of CO gas and classical high pressure synthesis.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.